Hollywood Stock Review Adds SLS Audio to Watch List

CLICK TO READ RESEARCH REPORT

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...

New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.

Video: 2020 Year of Crisis: Markets Melt Up (Bloomberg).

https://youtu.be/eL0YyWK_pcg Ask Yourself a Question, Do I Feel...

Dow 36,000 – S&P 500 4,500 – NASDAQ 15,000. Then a Crash. David Hunter.

David Hunter, chief macro strategist at Contrarian Macro Advisors. Interesting interview with David Hunter, who predicts some awful things...

Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.

‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg). (Bloomberg) -- Shares of the tiny biotechnology company...

Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?

Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come. Society Pass currently has...
Citius Pharmaceutical, CTXR, Biotech Stock Review

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!